Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Basun

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Magnetic Resonance Imaging|January 1, 1996
MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of lifeL O Wahlund, O Almkvist, H Basun, et al.
Brain Research|April 27, 1999
Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patientsA Garlind, A Brauner, B Höjeberg, et al.
Lancet (London, England)|October 7, 1995
Apolipoprotein E-epsilon 4 gene doseE Corder, H Basun, L Lannfelt, et al.
Neuroscience Letters|August 23, 1996
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-upM Blomberg, M Jensen, H Basun, et al.
International Archives of Occupational and Environmental Health|January 1, 1996
A follow-up study of five cases of aluminosisB Sjögren, K G Ljunggren, O Almkvist, et al.
Lancet (London, England)|October 22, 1994
Aluminosis and dementiaB Sjögren, K G Ljunggren, O Almkvist, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutationO Almkvist, K Axelman, H Basun, et al.
Lancet (London, England)|November 7, 1999
Reappraisal of aluminosis and dementiaB Sjögren, K G Ljunggren, H Basun, et al.
Lancet (London, England)|February 24, 1996
Attenuation of apolipoprotein E Epsilon4 allele gene dose in late ageE H Corder, H Basun, L Lannfelt, et al.
Biological Psychiatry|July 1, 1998
Psychotic symptoms and apolipoprotein E genotypes in an elderly populationY Forsell, H Basun, E H Corder, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Magnetic Resonance Imaging|January 1, 1996
MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of lifeL O Wahlund, O Almkvist, H Basun, et al.
Brain Research|April 27, 1999
Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patientsA Garlind, A Brauner, B Höjeberg, et al.
Lancet (London, England)|October 7, 1995
Apolipoprotein E-epsilon 4 gene doseE Corder, H Basun, L Lannfelt, et al.
Neuroscience Letters|August 23, 1996
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-upM Blomberg, M Jensen, H Basun, et al.
International Archives of Occupational and Environmental Health|January 1, 1996
A follow-up study of five cases of aluminosisB Sjögren, K G Ljunggren, O Almkvist, et al.
Lancet (London, England)|October 22, 1994
Aluminosis and dementiaB Sjögren, K G Ljunggren, O Almkvist, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutationO Almkvist, K Axelman, H Basun, et al.
Lancet (London, England)|November 7, 1999
Reappraisal of aluminosis and dementiaB Sjögren, K G Ljunggren, H Basun, et al.
Lancet (London, England)|February 24, 1996
Attenuation of apolipoprotein E Epsilon4 allele gene dose in late ageE H Corder, H Basun, L Lannfelt, et al.
Biological Psychiatry|July 1, 1998
Psychotic symptoms and apolipoprotein E genotypes in an elderly populationY Forsell, H Basun, E H Corder, et al.
Pageof 8